576 related articles for article (PubMed ID: 32975927)
1. Exploding the Repeat Length Paradigm while Exploring Amyloid Toxicity in Huntington's Disease.
Wetzel R
Acc Chem Res; 2020 Oct; 53(10):2347-2357. PubMed ID: 32975927
[TBL] [Abstract][Full Text] [Related]
2. Folding Landscape of Mutant Huntingtin Exon1: Diffusible Multimers, Oligomers and Fibrils, and No Detectable Monomer.
Sahoo B; Arduini I; Drombosky KW; Kodali R; Sanders LH; Greenamyre JT; Wetzel R
PLoS One; 2016; 11(6):e0155747. PubMed ID: 27271685
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease.
Drombosky KW; Rode S; Kodali R; Jacob TC; Palladino MJ; Wetzel R
Neurobiol Dis; 2018 Dec; 120():126-138. PubMed ID: 30171891
[TBL] [Abstract][Full Text] [Related]
4. Solid-State Nuclear Magnetic Resonance on the Static and Dynamic Domains of Huntingtin Exon-1 Fibrils.
Isas JM; Langen R; Siemer AB
Biochemistry; 2015 Jun; 54(25):3942-9. PubMed ID: 26020223
[TBL] [Abstract][Full Text] [Related]
5. A Targetable Self-association Surface of the Huntingtin exon1 Helical Tetramer Required for Assembly of Amyloid Pre-nucleation Oligomers.
Mishra R; Gerlach GJ; Sahoo B; Camacho CJ; Wetzel R
J Mol Biol; 2024 Jun; 436(12):168607. PubMed ID: 38734203
[TBL] [Abstract][Full Text] [Related]
6. Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments.
Jayaraman M; Kodali R; Sahoo B; Thakur AK; Mayasundari A; Mishra R; Peterson CB; Wetzel R
J Mol Biol; 2012 Feb; 415(5):881-99. PubMed ID: 22178474
[TBL] [Abstract][Full Text] [Related]
7. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.
Chen M; Wolynes PG
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517
[TBL] [Abstract][Full Text] [Related]
8. The polyglutamine domain is the primary driver of seeding in huntingtin aggregation.
Skeens A; Siriwardhana C; Massinople SE; Wunder MM; Ellis ZL; Keith KM; Girman T; Frey SL; Legleiter J
PLoS One; 2024; 19(3):e0298323. PubMed ID: 38483973
[TBL] [Abstract][Full Text] [Related]
9. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.
van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ
BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347
[TBL] [Abstract][Full Text] [Related]
10. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.
Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H
PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262
[TBL] [Abstract][Full Text] [Related]
11. SUMOylation Prevents Huntingtin Fibrillization and Localization onto Lipid Membranes.
Sedighi F; Adegbuyiro A; Legleiter J
ACS Chem Neurosci; 2020 Feb; 11(3):328-343. PubMed ID: 31880908
[TBL] [Abstract][Full Text] [Related]
12. Aggregation behavior of chemically synthesized, full-length huntingtin exon1.
Sahoo B; Singer D; Kodali R; Zuchner T; Wetzel R
Biochemistry; 2014 Jun; 53(24):3897-907. PubMed ID: 24921664
[TBL] [Abstract][Full Text] [Related]
13. β-hairpin-mediated nucleation of polyglutamine amyloid formation.
Kar K; Hoop CL; Drombosky KW; Baker MA; Kodali R; Arduini I; van der Wel PC; Horne WS; Wetzel R
J Mol Biol; 2013 Apr; 425(7):1183-97. PubMed ID: 23353826
[TBL] [Abstract][Full Text] [Related]
14. D-polyglutamine amyloid recruits L-polyglutamine monomers and kills cells.
Kar K; Arduini I; Drombosky KW; van der Wel PC; Wetzel R
J Mol Biol; 2014 Feb; 426(4):816-29. PubMed ID: 24291210
[TBL] [Abstract][Full Text] [Related]
15. Autophagy preferentially degrades non-fibrillar polyQ aggregates.
Zhao DY; Bäuerlein FJB; Saha I; Hartl FU; Baumeister W; Wilfling F
Mol Cell; 2024 May; 84(10):1980-1994.e8. PubMed ID: 38759629
[TBL] [Abstract][Full Text] [Related]
16. Huntington's disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart.
Melkani GC; Trujillo AS; Ramos R; Bodmer R; Bernstein SI; Ocorr K
PLoS Genet; 2013; 9(12):e1004024. PubMed ID: 24367279
[TBL] [Abstract][Full Text] [Related]
17. Effects of flanking sequences and cellular context on subcellular behavior and pathology of mutant HTT.
Chongtham A; Bornemann DJ; Barbaro BA; Lukacsovich T; Agrawal N; Syed A; Worthge S; Purcell J; Burke J; Chin TM; Marsh JL
Hum Mol Genet; 2020 Mar; 29(4):674-688. PubMed ID: 31943010
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of prenucleation, transient oligomerization of the Huntingtin exon 1 protein by human profilin I.
Ceccon A; Tugarinov V; Ghirlando R; Clore GM
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5844-5852. PubMed ID: 32127471
[TBL] [Abstract][Full Text] [Related]
19. Potential Transfer of Polyglutamine and CAG-Repeat RNA in Extracellular Vesicles in Huntington's Disease: Background and Evaluation in Cell Culture.
Zhang X; Abels ER; Redzic JS; Margulis J; Finkbeiner S; Breakefield XO
Cell Mol Neurobiol; 2016 Apr; 36(3):459-70. PubMed ID: 26951563
[TBL] [Abstract][Full Text] [Related]
20. A series of N-terminal epitope tagged Hdh knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal Huntingtin's polyglutamine stretch on CAG140 mouse model pathogenesis.
Zheng S; Ghitani N; Blackburn JS; Liu JP; Zeitlin SO
Mol Brain; 2012 Aug; 5():28. PubMed ID: 22892315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
